Trial site
Stockholm
- 7running trials
- 9closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- Stroke3 trials
- Familial hypercholesterolaemia2 trials
- Lung cancer2 trials
- Melanoma2 trials
- Multiple sclerosis2 trials
- ALS (motor neurone disease)1 trial
- Alzheimer disease1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Metastatic breast cancer1 trial
- Myeloproliferative neoplasms1 trial
- and 1 more
- Phase
- Phase 38 trials
- Phase 25 trials
- Phase 12 trials
- Phase 1/21 trial
- Status
- Active, not recruiting6 trials
- Completed5 trials
- Terminated4 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals16 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
Closed trials
Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Terminated
Study of Safety and Proof of the Mechanism of BLZ945 in ALS Patients
Completed
Terminated
Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
Completed
Terminated
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
Terminated
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 17 Nov 2026